在培养皿之外进行生物凝固,规模可达900升批次和米尺度柱
Dimitrios Terzis1,2, Camilla Perego3, Margherita Cappa3
1Faculty of Environment, Architecture and Civil Engineering (ENAC), Swiss Federal Institute of Technology, Lausanne (EPFL), Lausanne, Switzerland. dimitrios.terzis@epfl.ch.
Scientific reports
|January 24, 2025
概括
这项研究使用尿溶性细菌成功扩大了微生物诱导的石沉 (MICP). 优化过程实现了大量沙子的稳定生物水泥化,为可持续建筑和地球环境解决方案铺平了道路.
科学领域:
- 地质环境工程 - - 地质环境工程.
- 生物技术是生物技术.
- 可持续的建筑材料 可持续的建筑材料
背景情况:
- 微生物诱导的石沉 (MICP) 显示了可持续建筑和地球环境应用的前景.
- 将MICP从实验室扩展到工业体积提出了重大挑战.
- 尿溶性微生物是MICP过程的关键.
研究的目的:
- 为可扩展的MICP生产选和分析尿溶性微生物.
- 为了优化MICP种植和应用大规模项目.
- 为了证明MICP的可行性,用于生物水泥化大量的沙子.
主要方法:
- 从自然环境,银行和工业生物反应堆中选超过50种尿溶性细菌菌株.
- 在已识别的菌株中对尿溶性潜力的比较分析.
- 大规模种植 (最多5400升) 和在650公斤的沙柱中应用.
主要成果:
- 在自然环境中识别尿解性Sporosarcina物种.
- 一种参考银行菌株表现出最高的尿解率,并在没有污染的情况下在大规模培养中保持主导地位.
- 一个650公斤的沙柱的成功生物凝固,实现90-140kPa的未排水的特雷斯卡强度.
结论:
- 使用优化培养精选的尿溶性菌株,可以实现MICP的可扩展生产.
- 开发的方法确保了培养的稳定性和大量的有效生物凝固.
- 这项研究为MICP在建筑和地球环境工程中的实际应用提供了基础.
相关概念视频
Bioreactor Design and Operational System
220
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
220
Scale-Up Processes
119
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
119
Upstream Processing
102
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
102


